22 July 2015

Combination pulmonary hypertension therapies - required background therapy for future registration trials - Prof. Simon Gibbs

All credits: Peter Robbins

Presented at the 2nd Annual Drug & Development Symposium in London 2015.

 

Additional keywords: treatment,ethics,therapy,AMBITION,COMPASS-2

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg